CANCER

Cancer is one of the main research areas of Helsinki University Hospital HUS and University of Helsinki.

iCAN is an innovative multidisciplinary initiative that brings together some of the world’s leading actors in cancer genomics, translational and clinical cancer research, digital health, information technology, machine learning and business to solve one of the most pressing challenges of our time – cancer. This unique ecosystem will be based on two national cancer research Centers of Excellence at the University of Helsinki and the first Nordic Comprehensive Cancer Center at Helsinki University Hospital HUS with an aim to synergize with the national cancer center FICAN and its regional node FICAN South.

Helsinki University Hospital Comprehensive Cancer Center is the largest and most versatile cancer treatment center in Finland providing personalized cancer treatment. The center is part of the Helsinki University Hospital and is responsible for the oncological treatment of all adult cancer patients within the Hospital District of Helsinki and Uusimaa. Each year, HUS Cancer Center treats 21 000 patients, of whom approximately 8 000 are new patients.

The Faculty of medicine, University of Helsinki, ranked fifth in a survey of top European institutions in clinical medicine based on the number of citations per publication dealing with clinical medicine. The Faculty has trained numerous Finnish experts for diverse positions both in Finland and abroad. The high quality medical research conducted ranges from biological basic research to clinical applications. During the current strategic period, the Faculty’s research focus areas include malignancies, brain and mind, inflammation, metabolism and degenerative processes.

The Academic Medical Center Helsinki (AMCH) is an internationally renowned medical campus, comprising the Faculty of Medicine of the University of Helsinki, the HUS Helsinki University Hospital and the Institute for Molecular Medicine Finland (FIMM), which is part of the Helsinki Institute of Life Science (HiLIFE).